ASCO Lung Cancer Highlights, Part 8: The Biomarkers France Study (audio)
Share:
About
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews the landmark Biomarkers France study that tested a wide range of molecular markers in NSCLC.
GRACEcast Lung Cancer Audio
Science
Dr. Edward Garon, David Geffen School of Medicine at UCLA, reviews the landmark Biomarkers France study that tested a wide range of molecular markers in NSCLC.